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Research has demonstrated that a polymorphism in the cytochrome P450 (CYP1A2) gene impacts
caffeine metabolism. Further, one recent study reported that performance enhancement with caffeine
treatment differs across genotypes. PURPOSE: The purpose of the present study was to examine the
effects of a polymorphism in the cytochrome P450 (CYP1A2) gene on circulating caffeine concentrations
during exercise. METHODS: Twenty young (27 ± 3 years), novice cyclists (VO2max = 31.7 ± 6.8)
participated in three separate laboratory sessions. During the first visit, subjects underwent a graded
exercise test on a Lode Corival cycle ergometer to determine VO2max. Venous blood samples were
collected and immediately analyzed for genotype (AA genotype vs. C variant) via polymerase chain
reaction and gel electrophoresis. For the next two visits, 3 pieces of chewing gum (CAFF vs. PLA) was
administered in a counterbalanced, double blind manner. Subjects remained resting for 10 min then
completed a standard warm up on the cycle ergometer. Following the warm up, subjects cycled at 70%
VO2max (constant Wattage) for 15 min, rested for 10 min, then completed a 15 min performance ride.
Venous blood samples were collected at baseline (Base), during the warm-up (+25), and immediately
before (+50) and after (+65) the performance ride. Serum samples were analyzed for caffeine
concentrations via High Performance Liquid Chromatography. RESULTS: Ten subjects possessed the
AA genotype and 10 subjects possessed the C allele variant. Serum caffeine data were analyzed using a 2
(Genotype) by 4 (Time) analysis of variance (ANOVA). The ANOVA demonstrated a main effect of time
(p < 0.001) across both genotypes. Post hoc comparisons demonstrated that caffeine concentrations
increased from Base to +25 (1.4 ± .64 vs. 2.4 ± 1.1 mg · L-1 respectively, P < 0.01) and from +25 to +50
(2.4 ± 1.1 vs. 3.2 ± 1.5 mg · L-1, respectively, P = 0.012) then remained stable from +50 to +65 (3.2 ± 1.5
vs. 2.6 ± 1.2 mg · L-1, respectively, P = 0.380). No main effect of group was evident (p = 0.970). Further,
no genotype x time interaction was evident (p = 0.380). CONCLUSION: These data suggest that the
cytochrome P450 (CYP1A2) gene polymorphism did not impact circulating caffeine concentrations
during acute exercise.

